Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells

Apoptosis

Volumn 20, Issue 11, 2015, Pages 1499-1507

  Liu, Xianfang ^a,b   Guo, Sen ^a   Liu, Xiangguo ^a   Su, Ling ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; ATF3; Chaetocin; CHOP; DR5; SUV39H1

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CCAAT ENHANCER BINDING PROTEIN; CHAETOCIN; DEATH RECEPTOR 5; HISTONE METHYLTRANSFERASE; METHYLTRANSFERASE INHIBITOR; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ATF3 PROTEIN, HUMAN; DDIT3 PROTEIN, HUMAN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; PIPERAZINE DERIVATIVE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER THERAPY; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; EPIGENETICS; GENE SILENCING; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; UPREGULATION; CARCINOMA, NON-SMALL-CELL LUNG; DRUG EFFECTS; GENETICS; LUNG NEOPLASMS; METABOLISM; PATHOPHYSIOLOGY; TUMOR CELL LINE;

ACTIVATING TRANSCRIPTION FACTOR 3; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM STRESS; HUMANS; LUNG NEOPLASMS; PIPERAZINES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION FACTOR CHOP;

EID: 84942550534     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-015-1167-4     Document Type: Article

References (39)

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9-29
2. Balgkouranidou I, Liloglou T, Lianidou ES (2013) Lung cancer epigenetics: emerging biomarkers. Biomark Med 7:49-58
3. Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 11:726-734
4. Brazelle W, Kreahling JM, Gemmer J, Ma Y, Cress WD, Haura E et al (2010) Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells. PLoS One 5:e14335
5. Tang YA, Wen WL, Chang JW, Wei TT, Tan YH, Salunke S et al (2010) A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer. PLoS One 5:e12417
6. Camphausen K, Tofilon PJ (2007) Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J Clin Oncol 25:4051-4056
7. Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche TJ et al (2007) Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide. J Natl Cancer Inst 99:1107-1119
8. Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6:838-849
9. Cai L, Ma X, Huang Y, Zou Y, Chen X (2014) Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma. Oncol Rep 31:2593-2600
10. Yokoyama Y, Hieda M, Nishioka Y, Matsumoto A, Higashi S, Kimura H et al (2013) Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo. Cancer Sci 104:889-895
11. Benlhabib H, Mendelson CR (2011) Epigenetic regulation of surfactant frotein A gene (SP-A) expression in fetal lung reveals a critical role for Suv39h Methyltransferases during development and hypoxia. Mol Cell Biol 31:1949-1958
12. Sidler C, Woycicki R, Li D, Wang B, Kovalchuk I, Kovalchuk O (2014) A role for SUV39H1-mediated H3K9 trimethylationin the control of genome stability and senescence in WI38 human diploid lung fibroblasts. Aging (Albany NY) 6:545-563
13. Pandey M, Sahay S, Tiwari P, Upadhyay DS, Sultana S, Gupta KP (2014) Involvement of EZH2, SUV39H1, G9a and associated molecules in pathogenesis of urethane induced mouse lung tumors: potential targets for cancer control. Toxicol Appl Pharmacol 280:296-304
14. Greiner D, Bonaldi T, Eskeland R, Roemer E, Imhof A (2005) Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat Chem Biol 1:143-145
15. Sekita S, Yoshihira K, Natori S, Udagawa S, Muroi T, Sugiyama Y et al (1981) Mycotoxin production by Chaetomium spp. and related fungi. Can J Microbiol 27:766-772
16. Freire FC, Kozakiewicz Z, Paterson RR (2000) Mycoflora and mycotoxins in Brazilian black pepper, white pepper and Brazil nuts. Mycopathologia 149:13-19
17. Tibodeau JD, Benson LM, Isham CR, Owen WG, Bible KC (2009) The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase. Antioxid Redox Signal 11:1097-1106
18. Isham CR, Tibodeau JD, Jin W, Xu R, Timm MM, Bible KC (2007) Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress. Blood 109:2579-2588
19. Lee YM, Lim JH, Yoon H, Chun YS, Park JW (2011) Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia-inducible factor 1alpha pre-mRNA in mice and in vitro. Hepatology 53:171-180
20. Chaib H, Nebbioso A, Prebet T, Castellano R, Garbit S, Restouin A et al (2012) Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. Leukemia 26:662-674
21. Cotter TG (2009) Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 9:501-507
22. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495-516
23. Yagita H, Takeda K, Hayakawa Y, Smyth MJ, Okumura K (2004) TRAIL and its receptors as targets for cancer therapy. Cancer Sci 95:777-783
24. Gonzalvez F, Ashkenazi A (2010) New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29:4752-4765
25. Elrod HA, Sun SY (2008) Modulation of death receptors by cancer therapeutic agents. Cancer Biol Ther 7:163-173
26. Sun SY (2005) Chemopreventive agent-induced modulation of death receptors. Apoptosis 10:1203-1210
27. Oh YT, Liu X, Yue P, Kang S, Chen J, Taunton J et al (2010) ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1. J Biol Chem 285:41310-41319
28. Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7:880-885
29. Sun SY, Liu X, Zou W, Yue P, Marcus AI, Khuri FR (2007) The farnesyltransferase inhibitor lonafarnib induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells. J Biol Chem 282:18800-18809
30. Thompson MR, Xu D, Williams BR (2009) ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med (Berl) 87:1053-1060
31. Liu G, Su L, Hao X, Zhong N, Zhong D, Singhal S et al (2012) Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells. J Cell Mol Med 16:1618-1628
32. Su L, Liu G, Hao X, Zhong N, Zhong D, Liu X et al (2011) Death receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells. Eur J Cancer 47:2471-2478
33. Liu X, Yue P, Zhou Z, Khuri FR, Sun SY (2004) Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 96:1769-1780
34. Yang L, Su L, Cao C, Xu L, Zhong D, Liu X (2013) The chalcone 2′-hydroxy-4′,5′-dimethoxychalcone activates death receptor 5 pathway and leads to apoptosis in human nonsmall cell lung cancer cells. IUBMB Life 65:533-543
35. Xu L, Su L, Liu X (2012) PKCdelta regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells. Mol Cancer Ther 11:2174-2182
36. Kim I, Xu W, Reed JC (2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 7:1013-1030
37. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H et al (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12:982-995
38. Yamaguchi H, Wang HG (2004) CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem 279:45495-45502
39. Hai T, Jalgaonkar S, Wolford CC, Yin X (2011) Immunohistochemical detection of activating transcription factor 3, a hub of the cellular adaptive-response network. Methods Enzymol 490:175-194